ClinicalTrials.Veeva

Menu

Determine Long-Term Safety and Tolerability of Pregabalin in Patients With Anxiety Disorders.

Pfizer logo

Pfizer

Status and phase

Completed
Phase 3

Conditions

Anxiety Neuroses

Treatments

Drug: Pregabalin

Study type

Interventional

Funder types

Industry

Identifiers

NCT00150449
1008-100

Details and patient eligibility

About

Determine long-term safety and tolerability of pregabalin in patients with anxiety disorders.

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Must have completed the double-blind portion of the preceding trial
  • Completed any protocol specified withdrawal phase and follow-up visits.

Exclusion criteria

  • Patient cannot participate if they experienced a serious adverse event or a nonserious, but medically significant adverse event during the preceding efficacy study that was judged to be related to the study medication.

Trial design

Primary purpose

Treatment

Allocation

Non-Randomized

Interventional model

Single Group Assignment

Masking

None (Open label)

Trial contacts and locations

138

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2024 Veeva Systems